Target intelligence / Profile preview

Host cell surface receptors for Ebola virus glycoprotein

Molecular classification
Receptor, Enzyme, Other
01

Overview

The host cell surface receptors for the Ebola virus glycoprotein (GP) are a diverse group of proteins that facilitate the initial attachment and internalization of the virus into host cells. Unlike many viruses that use a single specific cell surface receptor, Ebola virus (EBOV) utilizes multiple attachment factors, including T-cell immunoglobulin and mucin domain 1 (TIM-1), Tyro3/Axl/Mer (TAM) family receptors (particularly Axl), and various C-type lectins such as DC-SIGN and L-SIGN (Alvarez et al., 2002; Shimojima et al., 2007; Kondratowicz et al., 2011). These receptors interact with either the glycans on the viral GP or phosphatidylserine (PS) on the viral envelope, triggering macropinocytosis or other endocytic pathways to bring the virion into the cell (Hunt et al., 2011; Nanbo et al., 2010). Once internalized, the virus is trafficked to late endosomes where the GP is proteolytically processed by cathepsins to expose the binding site for the essential intracellular receptor, Niemann-Pick C1 (NPC1), which mediates membrane fusion and viral genome release (Carette et al., 2011; Cote et al., 2011). Targeting these cell surface receptors or the subsequent endosomal entry steps represents a significant therapeutic strategy to prevent viral infection and spread, with several small molecules and antibodies currently under investigation (Yuan et al., 2015; Stewart et al., 2019).

Other names
Ebola virus attachment factorsEBOV entry receptorsT-cell immunoglobulin and mucin domain 1 (TIM-1)Axl receptor tyrosine kinaseDC-SIGN (CD209)L-SIGN (CLEC4M)hMGL (CLEC10A)LSECtin (CLEC4G)Beta-1 integrin (ITGB1)Folate receptor alpha (FR-alpha)
02

Mechanism of action

Inhibition of viral attachment to cell surface factors, blocking of macropinocytosis-mediated internalization, and prevention of endosomal glycoprotein-receptor interactions.

03

Biological functions

Viral entryMacropinocytosisCell adhesionImmune responsePhosphatidylserine binding
04

Disease associations

Infection
05

Safety considerations

Potential for Niemann-Pick-like symptoms if NPC1 is affectedAlteration of immune signaling and cell survival pathwaysOff-target effects on physiological macropinocytosis and clearance of apoptotic cells
06

Interacting drugs

R428 (BGB324)

4 more in the full profile.

07

Biomarkers

Ebola virus RNA (viral load)Ebola virus glycoprotein (GP) levelsTIM-1 expression levelsAxl expression levels

Beyond the preview

Go deeper on Host cell surface receptors for Ebola virus glycoprotein.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host cell surface receptors for Ebola virus glycoprotein.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call